Thursday, January 07, 2021 1:17:13 PM
With this company, history is important. The wasteful spending and dilution is why it is where it is today.
Yes, with new leadership, things will hopefully improve.
The quote, "The Company's goal is to achieve positive Adjusted EBITDA in Q2 2021." is meaningless to me since different variations have been quoted by company management for many quarters, and never achieved. That's another reason they are where they are.
Maybe yes, maybe no. ACB history suggests these "one time" costs will continue for a while under various categories. The company has taken hundreds of millions of dollars of these "one time" expenses.
That doesn't mean we have to agree.
Yes, with new leadership, things will hopefully improve.
The quote, "The Company's goal is to achieve positive Adjusted EBITDA in Q2 2021." is meaningless to me since different variations have been quoted by company management for many quarters, and never achieved. That's another reason they are where they are.
Another $47.4 million in restructuring payments, such as contract and employee termination costs?
I think not.
Maybe yes, maybe no. ACB history suggests these "one time" costs will continue for a while under various categories. The company has taken hundreds of millions of dollars of these "one time" expenses.
That doesn't mean we have to agree.
"Sometimes people don't want to hear the truth because they don't want their illusions destroyed." - Friedrich Nietzsche
"None so deaf as those that will not hear. None so blind as those that will not see." - Matthew Henry
Recent ACB News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/28/2026 12:15:03 PM
- Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets • PR Newswire (Canada) • 04/28/2026 10:53:00 AM
- Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets • PR Newswire (US) • 04/28/2026 10:53:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/16/2026 08:18:36 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/15/2026 11:21:53 AM
- Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets • PR Newswire (Canada) • 04/15/2026 11:05:00 AM
- Aurora Cannabis Accelerates Global Medical Cannabis Leadership with Accretive Acquisition of Safari Flower Company, Expanding EU GMP Capacity to Serve Growing High Margin International Markets • PR Newswire (US) • 04/15/2026 11:05:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/30/2026 11:29:57 AM
- Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year • PR Newswire (US) • 03/30/2026 11:03:00 AM
- Aurora Recognized for Executive Gender Diversity by the Globe & Mail for Second Consecutive Year • PR Newswire (Canada) • 03/30/2026 11:03:00 AM
- Aurora to Participate in the TD Cowen 46th Annual Health Care Conference • PR Newswire (US) • 02/17/2026 11:39:00 PM
- Aurora to Participate in the TD Cowen 46th Annual Health Care Conference • PR Newswire (Canada) • 02/17/2026 11:39:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/12/2026 09:26:03 PM
- Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis • PR Newswire (US) • 02/12/2026 09:05:00 PM
- Aurora to Ring the Nasdaq Closing Bell on Wednesday, February 18, 2026, Reinforcing Strategic Focus on Global Medical Cannabis • PR Newswire (Canada) • 02/12/2026 09:05:00 PM
- Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand • PR Newswire (Canada) • 02/11/2026 12:00:00 PM
- Aurora Advances Global Medical Growth Strategy with Portfolio Expansion in Australia & New Zealand • PR Newswire (US) • 02/11/2026 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 09:44:28 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 02:45:22 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 12:27:19 PM
- Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)] • Edgar (US Regulatory) • 02/04/2026 12:10:54 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/04/2026 12:05:38 PM
- Aurora Cannabis Announces Filing of Prospectus Supplement for At-The-Market Offering Program • PR Newswire (Canada) • 02/04/2026 12:00:00 PM
- Aurora Cannabis Announces Fiscal 2026 Third Quarter Results • PR Newswire (Canada) • 02/04/2026 12:00:00 PM
- Aurora Cannabis Announces Fiscal 2026 Third Quarter Results • PR Newswire (US) • 02/04/2026 12:00:00 PM
